Sanofi Genzyme

Research Project Team Leader

Posted on: 14 Sep 2023

Cambridge, MA

Job Description

Positioned within the Inflammation & Immunology Therapeutic Area Research organization, you will provide strategic and operational oversight on projects from discovery through development candidate nomination in a matrixed setting and serve on early development teams as the research representative. You will play a central role in delivering high-quality clinical development candidates to build a world-class immunology portfolio.

Key responsibilities

Lead cross-functional project teams, represent project teams at all levels of the organization and ensure smooth transition of the project through governance committees.

Oversee the strategy, resourcing and operational aspects of the project, and be accountable for the robustness of data and quality of the overall project package for milestone transitions.

Operate with a portfolio mindset and recommend Go / pause / No-Go decisions for projects based on internal data, timelines as well as competitive landscape. Propose, generate buy-in and operationalize an accelerated path for high-impact, time-sensitive projects.

Provide clear viewpoints and guidance on strategic positioning and differentiation of projects.

Translate project strategy and progress into meaningful presentations and communications.

Serve as a key contact for TA Research Head, TA leadership and key stakeholders across Sanofi.

Serve as an advisor, mentor and thought partner to functional area leads within the project, including biology leads and modality leads.

Develop and maintain a strong and collaborative working relationship with key stakeholders in therapeutic area research, development, commercial, platform as well as corporate functions.

Required profile

PhD in immunology or an adjacent discipline in biology.

7+ years of experience in pharmaceutical R&D, preferably in Immunology.

A broad understanding of targets, target classes, disease indications, unmet medical needs, modalities as well as therapeutic product landscape and trends in Immunology.

Strong scientific knowledge and insight in all aspects of drug discovery processes and workflows in preclinical research, as well as experience working with development, regulatory and commercial functions.

Successful track record of delivering clinical candidates by managing large cross-functional teams with complex scope across geographies.

Excellent scientific, interpersonal, listening, communication, collaboration, presentation, negotiation and conflict-resolution skills.

Strong project and program leadership skills and a solid track record of executional excellence, moving with fast lead-time from idea to action.

Ability to build effective teams through “alignment, execution and renewal” in a complex and fast changing environment independently from reporting lines.

Ability to influence and persuade key stakeholders / decision makers to obtain buy-in.

Ability to think strategically to develop a compelling vision, be creative to provide novel solutions, as well as be detail-oriented to solve project-intrinsic problems and challenges.

Authentic and strong communicator with an ability to discuss at all levels within Sanofi and externally, ensuring an impactful communication. Ability to facilitate and steer difficult conversations to sustainable outcomes and move to action. 

Preferred profile

Experience with multiple drug modalities (small molecules, biologics, multi-specifics)

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

#GD-SA 
#LI-SA

Sanofi Genzyme

Cambridge, MA

As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.

Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.

Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.

Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.